Management tracks: Ex-MiMedx execs to lose compensation

MiMedx Group Inc. (NASDAQ:MDXG) said it will treat four resignations announced this summer, including that of former Chairman and CEO Parker Petit, as "for cause" terminations. The regenerative medicine and biologics company said the decision, made by the board and compensation committee, was based on an independent investigation by its audit committee that found "the ex-employees engaged in, among other things, conduct detrimental to the business and reputation of the Company."

The decision also applies to former President and COO William Taylor, a director; former CFO and Principal Accounting Officer Michael Senken; and former VP and Corporate Controller and Treasurer John Cranston. All resigned from their positions in June. Petit resigned as a board member on Friday...